Bio-Rad Laboratories, Inc.
BIO
Jodie situation report
Bio-Rad Laboratories, Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 39 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.
- Net income increased 16.9% versus the comparable filing period.
- Revenue decreased 0.1% versus the comparable filing period.
- BIO's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if BIO's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind BIO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SOAGYFiling-linked nameinvesteeApr 30, 2026 ▾
“The change in the fair market value primarily resulted from the recognition of holding losses of $727.7 million in the first quarter of 2026 compared to holding gains of $29.0 million in the first quarter of 2025 on our investment in Sartorius.”
ABTAbbott LaboratoriescompetitorFeb 13, 2026 ▾
“Major competitors for our products in the Clinical Diagnostics segment include Abbott Laboratories, Becton Dickinson, bioMérieux, Danaher, DiaSorin, Werfen, QuidelOrtho, Roche, Siemens Healthineers, Thermo Fisher Scientific and Tosoh.”
Depended on by
QDELQuidelOrtho CorporationcompetitorFeb 19, 2026 ▾
“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and We…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 11 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BIO is currently a Follower in the organic co-movement group Healthcare–Defense Mix. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for BIO; it is not active in the latest market snapshot.